ArticleCancer science2024

Phase I trial of apatinib and paclitaxel+oxaliplatin+5-FU/levoleucovorin for treatment-naïve advanced gastric cancer.

Shen Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.